Press Play with Madeleine Brand

SCOTUS ruling puts Purdue Pharma opioid settlement in peril

It took years to negotiate a settlement between Purdue Pharma and victims of the opioid epidemic. Today, SCOTUS ruled that bankruptcy law shouldn't be used to shield the company's owners from future lawsuits.

By Madeleine Brand • Jun 27, 2024 • 1 min read

It took years to negotiate a settlement between Purdue Pharma and victims of the opioid epidemic. Today, SCOTUS ruled that bankruptcy law shouldn't be used to shield the company's owners from future lawsuits.

Madeleine Brand
Host, 'Press Play'
Sarah Sweeney
Vice President of Talk Programming, KCRW
Angie Perrin
Producer, Press Play
Amy Ta
Digital News & Culture Editor
Jessica Levinson
Professor, LMU's Loyola Law School in Los Angeles

Press Play with Madeleine Brand

SCOTUS ruling puts Purdue Pharma opioid settlement in peril

It took years to negotiate a settlement between Purdue Pharma and victims of the opioid epidemic. Today, SCOTUS ruled that bankruptcy law shouldn't be used to shield the company's owners from future lawsuits.

Share

Press Play with Madeleine Brand

SCOTUS ruling puts Purdue Pharma opioid settlement in peril

It took years to negotiate a settlement between Purdue Pharma and victims of the opioid epidemic. Today, SCOTUS ruled that bankruptcy law shouldn't be used to shield the company's owners from future lawsuits.

Share